Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children

被引:0
|
作者
Byung Ok Kwak
Hoan Jong Lee
Hyun Mi Kang
Chi Eun Oh
Eun Hwa Choi
机构
[1] Seoul National University Children’s Hospital,Division of Pediatric Infectious Diseases, Department of Pediatrics
[2] Konkuk University School of Medicine,Department of Microbiology
[3] Seoul National University College of Medicine,Department of Pediatrics
[4] Kosin University College of Medicine,Department of Pediatrics
来源
Archives of Virology | 2017年 / 162卷
关键词
Varicella-zoster virus; Genotype; Children;
D O I
暂无
中图分类号
学科分类号
摘要
This study was performed to differentiate vaccine-type strains from wild-type strains and determine the genotype of varicella-zoster virus (VZV) in 51 Korean children. A sequencing analysis of ORF 62 identified two cases of herpes zoster caused by the vaccine-type virus, without a previous history of varicella, 22 months and 5 months after VZV vaccination. The wild-type strain was identified in the remaining children. A genotype analysis of ORF 22 amino acids revealed genotype J in all children except one. Genotype E was identified in an infant with varicella imported from Egypt.
引用
收藏
页码:1725 / 1730
页数:5
相关论文
共 50 条
  • [21] RECURRENT VARICELLA-ZOSTER VIRUS-INFECTIONS IN APPARENTLY IMMUNOCOMPETENT CHILDREN
    JUNKER, AK
    ANGUS, E
    THOMAS, EE
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (08) : 569 - 575
  • [22] Novel polyvalent live vaccine against varicella-zoster and mumps virus infections
    Matsuura, Masaaki
    Somboonthum, Pranee
    Murakami, Kouki
    Ota, Megumi
    Shoji, Masaki
    Kawabata, Kenji
    Mizuguchi, Hiroyuki
    Gomi, Yasuyuki
    Yamanishi, Koichi
    Mori, Yasuko
    MICROBIOLOGY AND IMMUNOLOGY, 2013, 57 (10) : 704 - 714
  • [23] Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
    Miriam Wiese-Posselt
    Anette Siedler
    Annette Mankertz
    Andreas Sauerbrei
    Hartmut Hengel
    Ole Wichmann
    Christina Poethko-Müller
    BMC Infectious Diseases, 17
  • [24] Enhancement of Varicella-Zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins
    Schoonbroodt, S
    Piette, J
    Baudoux, L
    Defechereux, P
    Rentier, B
    Merville, MP
    JOURNAL OF MEDICAL VIROLOGY, 1996, 49 (04) : 264 - 273
  • [25] CURRENT MANAGEMENT OF VARICELLA-ZOSTER VIRUS-INFECTIONS
    BALFOUR, HH
    JOURNAL OF MEDICAL VIROLOGY, 1993, : 74 - 81
  • [26] Isolation of Varicella-zoster virus from vesicles in children with varicella
    Ozaki, T
    Kajita, Y
    Namazue, J
    Yamanishi, K
    JOURNAL OF MEDICAL VIROLOGY, 1996, 48 (04) : 326 - 328
  • [27] Novel compounds for the treatment of varicella-zoster virus infections
    Visalli, RJ
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (03) : 355 - 365
  • [28] Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany
    Sauerbrei, A.
    Wutzler, P.
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (07) : 1025 - 1031
  • [29] Varicella-zoster virus seroprevalence in children and adolescents in the prevaricella vaccine era, Germany
    Wiese-Posselt, Miriam
    Siedler, Anette
    Mankertz, Annette
    Sauerbrei, Andreas
    Hengel, Hartmut
    Wichmann, Ole
    Poethko-Mueller, Christina
    BMC INFECTIOUS DISEASES, 2017, 17
  • [30] Perspectives on Vaccines Against Varicella-Zoster Virus Infections
    Gershon, Anne A.
    Gershon, Michael D.
    VARICELLA-ZOSTER VIRUS, 2010, 342 : 359 - 372